You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Eli Lilly obesity pill disappoints in trial, sending shares down 12% ○

found 2025 › Aug › 07 (Thu) @ 11:25 UTC

Rival Novo Nordisk’s stock climbs 12%